Immunitybio

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$2.61-$10.53
Market Cap
$1.9B
Shares Short
49M

Financials

See more
Revenue (12 Mos)
$7.3M
Revenue Growth (YoY)
7,346.3%
Gross Profit (12 Mos)
$240,000
Diluted EPS
-$0.90

News

See more

Yahoo Finance • 5 months ago

Chief Scientific Officer Patrick Soon-Shiong, ImmunityBio, Inc.'s (NASDAQ:IBRX) largest shareholder sees value of holdings go down 6.5% after recent drop

Yahoo Finance • 7 months ago

ImmunityBio Announces 2024 Annual Meeting of Stockholders with Company Update

Yahoo Finance • 11 months ago

ImmunityBio Quality-of-Life Study in BCG-Unresponsive Bladder Cancer Trial Indicates Improved Physical Function in the 71% Complete Responders Suggesting a Favorable Risk-Benefit Ratio for N-803 Plus BCG

Yahoo Finance • last year

ImmunityBio Announces Biological License Application Resubmission for N-803 in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer Carcinoma-In-Situ

About

CEO
Mr. Richard Gerald Adcock
Address
3530 John Hopkins Court, San Diego, CA, United States, 92121
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
672